Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Strategic Alliance Partners

August 20, 2020

In our exclusive interview, Dr. Levy discusses the challenges of targeting KRAS and highlighted some of the investigational agents directed toward KRAS G12C mutations that have emerged in the NSCLC pipeline.

May 18, 2020

Treatment approaches are being refined by the primary location of gastroesophageal junction tumors.

May 18, 2020

Treatment approaches are being refined by the primary location of gastroesophageal junction tumors.

May 15, 2020

Jean Wright, MD, discusses radiation considerations in breast cancer.

May 14, 2020

Jean Wright, MD, discusses radiation considerations in breast cancer.

May 04, 2020

Nivolumab, when administered approximately 4 weeks prior to surgery in patients with Merkel cell carcinoma, was found to be tolerable and to induce pathological complete responses and radiographic tumor regressions.

May 02, 2020

Jean Wright, MD, discusses proton versus photon radiotherapy in breast cancer.

April 28, 2020

Amanda Nickles Fader, MD, discusses the rationale for a phase II study and explains how the findings could open the door to other treatment options for women with uterine serous carcinoma.

April 24, 2020

Emmanuel S. Antonarakis, MBBCh, discusses the efficacy of radium-223 plus sipuleucel-T in patients with bone-metastatic castration-resistant prostate cancer and the next steps for research for this combination.

April 24, 2020

Amanda Nickles Fader, MD, discusses the utility of trastuzumab plus chemotherapy in HER2-positive uterine serous carcinoma.

April 15, 2020

Amanda Nickles Fader, MD, discusses the rationale for utilizing HER2/neu as a target in uterine serous carcinoma.

April 14, 2020

Tania Jain, MBBS, discusses the potential for graft-versus-host disease as a complication of allogeneic stem cell transplant.

April 09, 2020

Emmanuel S. Antonarakis, MBBCh, discusses the design of a randomized phase II study of sipuleucel-T with or without radium-223 dichloride in men with asymptomatic bone-metastatic castrate-resistant prostate cancer.

April 08, 2020

Tania Jain, MBBS, sheds light on the mutations that confer worse prognosis in myelofibrosis.

April 04, 2020

Benjamin P. Levy, MD, discusses emerging biomarkers and their respective therapies in lung cancer.

April 03, 2020

Tania Jain, MBBS, discusses treatment options for patients with myelofibrosis who progress following allogeneic stem cell transplant.

March 31, 2020

Emmanuel S. Antonarakis, MBBCh, discusses the utility of sipuleucel-T plus radium-223 in nonmetastatic castration-resistant prostate cancer.

March 28, 2020

Emmanuel S. Antonarakis, MBBCh, discusses the optimal use of PD-1/PD-L1 monotherapy in prostate cancer.

March 27, 2020

Tania Jain, MBBS, discusses blood count recovery in patients with hematology malignancies who receive CAR T-cell therapy.

March 23, 2020

Tania Jain, MBBS, discusses the role of allogeneic stem cell transplant in myelofibrosis.